Author: devon graham

https://link.springer.com/article/10.1007/s10072-020-04910-8 Rationale The activation of the glucagon-like peptide-1 receptor (GLP-1R) has been purported to have antidepressant-like and cognitive-enhancing effects. Many people suffering from major depressive disorder (MDD) also experience deficits in cognition. While currently approved antidepressant pharmacotherapies can alleviate the mood symptoms in some patients, they do...

X
Skip to toolbar